Corrections: A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study (The Lancet Infectious Diseases (2018) 18(4) (431–440), (S1473309918300045) (10.1016/S1473-3099(18)30004-5));A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study

The Lancet Infectious Diseases

Volumn 18, Issue 4, 2018, Pages 431-440

  Walker, Timothy M ^a   Merker, Matthias ^h   Knoblauch, Astrid M ^b   Helbling, Peter ^c   Schoch, Otto D ^d   van der Werf, Marieke J ^e   Kranzer, Katharina ^h   Fiebig, Lena ⁱ   Kröger, Stefan ⁱ   Haas, Walter ⁱ   Hoffmann, Harald ^j   Indra, Alexander ^k   Egli, Adrian ^b,l   Cirillo, Daniela M ^m   Robert, Jérôme ⁿ   Rogers, Thomas R ^o,p   Groenheit, Ramona ^q   Mengshoel, Anne T ^r   Mathys, Vanessa ^s   Haanperä, Marjo ^t   Soolingen, Dick van ^f,g   Niemann, Stefan ^h   Böttger, Erik C ^d   Keller, Peter M ^d   Avsar, Korkut ^u   Bauer, Christoph ^u   Bernasconi, Enos ^u   Borroni, Emanuele ^u   Brusin, Sergio ^u   Coscollá Dévis, Mireia ^u   Crook, Derrick W ^u   Dedicoat, Martin ^u   Fitzgibbon, Margaret ^u   Gagneux, Sébastien ^u   Geiger, Francisca ^u   Guthmann, Jean Paul ^u   Hendrickx, David ^u   Hoffmann Thiel, Sabine ^u   van Ingen, Jakko ^u   Jackson, Sarah ^u   Jaton, Katia ^u   Lange, Christoph ^u   Mazza Stalder, Jessica ^u   O'Donnell, Joan ^u   Opota, Onya ^u   Peto, Tim E A ^u   Preiswerk, Benjamin ^u   Roycroft, Emma ^u   Sato, Mariko ^u   Schacher, Regina ^u   Schulthess, Bettina ^u   Smith, E Grace ^u   Soini, Hanna ^u   Sougakoff, Wladimir ^u   Tagliani, Elisa ^u   Utpatel, Christian ^u   Veziris, Nicolas ^u   Wagner Wiening, Christiane ^u   Witschi, Mark ^u   more..

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BASEL   (Switzerland)

^c FEDERAL OFFICE OF PUBLIC HEALTH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^g Laboratory for Infectious Diseases and Perinatal Screening   (Netherlands)

^h RESEARCH CENTER BORSTEL   (Germany)

ⁱ ROBERT KOCH INSTITUTE   (Germany)

^j WORLD HEALTH ORGANIZATION   (Switzerland)

^k AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^l UNIVERSITY HOSPITAL BASEL   (Switzerland)

^m SAN RAFFAELE HOSPITAL   (Italy)

ⁿ INSERM   (France)

^o ST JAMES S HOSPITAL   (Ireland)

^p TRINITY COLLEGE DUBLIN   (Ireland)

^q SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^r NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^s OD Communicable and Infectious Diseases   (Belgium)

^t NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^u National Institute for Health and Welfare ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CAPREOMYCIN; ETHAMBUTOL; ISONIAZID PLUS RIFAMPICIN; PROTEIN TLYA; PYRAZINAMIDE; UNCLASSIFIED DRUG; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CLONE; DJIBOUTI; EPIDEMIC; EPIDEMIOLOGICAL DATA; EUROPE; FEMALE; GENE MUTATION; HUMAN; MALE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SUDAN; TANDEM REPEAT; TRAVEL; ADOLESCENT; AFRICA; ANIMAL; BACTERIAL GENOME; CHILD; CLASSIFICATION; CLUSTER ANALYSIS; DISEASE TRANSMISSION; DRUG EFFECT; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MIGRANT; MOLECULAR TYPING; VARIABLE NUMBER OF TANDEM REPEAT; WHOLE GENOME SEQUENCING; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICA; ANIMALS; ANTITUBERCULAR AGENTS; CHILD; CLUSTER ANALYSIS; DISEASE TRANSMISSION, INFECTIOUS; EMIGRANTS AND IMMIGRANTS; EUROPE; FEMALE; GENOME, BACTERIAL; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MINISATELLITE REPEATS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; TUBERCULOSIS, MULTIDRUG-RESISTANT; WHOLE GENOME SEQUENCING; YOUNG ADULT;

EID: 85040100945     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(18)30024-0     Document Type: Erratum

References (27)

1. WHO. Global tuberculosis report 2017. 2017, World Health Organization, Geneva.
2. Comas, I, Coscolla, M, Luo, T, et al. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 45 (2013), 1176–1182.
3. Office of the UN High Commissioner for Human Rights. “Detained and dehumanised”. Report on human rights abuses against migrants in Libya. http://www.ohchr.org/Documents/Countries/LY/DetainedAndDehumanised_en.pdf, Dec 13, 2016 (accessed Nov 10, 2017).
4. McIlvain Moran, A, Mulugetta, Y, Raleigh, C, Climate change and security in Africa. Clear risks, nuanced impacts. 2014, Global Military Advisory Council on Climate Change, Baridhara.
5. UN News Centre. Mediterranean death toll in 2016 ‘worst we have seen’ – UN refugee agency. http://www.un.org/apps/news/story.asp?NewsID=55389#.WQMXxVLMxZ0 (accessed Nov 10, 2017).
6. Herzmann, C, Golakov, M, Malekzada, F, Lonnroth, K, Kranzer, K, Radiological screening of refugees in Germany. Eur Resp J, 49, 2017, 5.
7. Chan, IH, Kaushik, N, Dobler, CC, Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis. Lancet Infect Dis 17 (2017), 770–779.
8. Bozorgmehr, K, Post-migration follow-up of migrants at risk of tuberculosis. Lancet Infect Dis, 17, 2017, 692.
9. Office of the UN High Commissioner for Refugees. Europe refugees and migrants emergency response: nationality of arrivals to Greece, Italy and Spain. https://data2.unhcr.org/ar/documents/download/53447, December, 2016 (accessed Nov 17, 2017).
10. Hargreaves, S, Lönnroth, K, Nellums, LB, et al. Multidrug-resistant tuberculosis and migration to Europe. J Clin Microbiol lnfect Dis 23 (2017), 141–146.
11. Allix-Béguec, C, Wahl, C, Hanekom, M, et al. Proposal of a consensus set of hypervariable mycobacterial interspersed repetitive-unit-variable-number tandem-repeat loci for subtyping of Mycobacterium tuberculosis Beijing isolates. J Clin Microbiol 52 (2014), 164–172.
12. Field, N, Cohen, T, Struelens, M, et al. Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement. Lancet Infect Dis 14 (2014), 341–352.
13. Guindon, S, Dufayard, JF, Lefort, V, Anisimova, M, Hordijk, W, Gascuel, O, New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 59 (2010), 307–321.
14. Coll, F, McNerney, R, Guerra-Assunção, JA, et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat Commun, 5, 2014, 4812.
15. Maus, CE, Plikaytis, BB, Shinnick, TM, Mutation of tlyA confers capreomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 49 (2005), 571–577.
16. Engstrom, A, Perskvist, N, Werngren, J, Hoffner, SE, Jureen, P, Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis. J Antimicrob Chemother 66 (2011), 1247–1254.
17. Ford, CB, Lin, PL, Chase, MR, et al. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 43 (2011), 482–486.
18. Walker, TM, Ip, CL, Harrell, RH, et al. Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study. Lancet Infect Dis 13 (2013), 137–146.
19. Roetzer, A, Diel, R, Kohl, TA, et al. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med, 10, 2013, e1001387.
20. Bryant, JM, Schürch, AC, van Deutekom, H, et al. Inferring patient to patient transmission of Mycobacterium tuberculosis from whole genome sequencing data. BMC Infect Dis, 13, 2013, 110.
21. Hatherell, HA, Colijn, C, Stagg, HR, Jackson, C, Winter, JR, Abubakar, I, Interpreting whole genome sequencing for investigating tuberculosis transmission: a systematic review. BMC Med, 14, 2016, 21.
22. Akbergenov, R, Shcherbakov, D, Matt, T, et al. Molecular basis for the selectivity of antituberculosis compounds capreomycin and viomycin. Antimicrob Agents Chemother 55 (2011), 4712–4717.
23. Walker, TM, Kohl, TA, Omar, SV, et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect Dis 15 (2015), 1193–1202.
24. Shcherbakov, D, Akbergenov, R, Matt, T, Sander, P, Andersson, DI, Böttger, EC, Directed mutagenesis of Mycobacterium smegmatis 16S rRNA to reconstruct the in vivo evolution of aminoglycoside resistance in Mycobacterium tuberculosis. Mol Microbiol 77 (2010), 830–840.
25. Freihofer, P, Akbergenov, R, Teo, Y, Juskeviciene, R, Andersson, DI, Böttger, EC, Nonmutational compensation of the fitness cost of antibiotic resistance in mycobacteria by overexpression of tlyA rRNA methylase. RNA 22 (2016), 1836–1843.
26. Dara, M, Solovic, I, Sotgiu, G, et al. Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices. Eur Respir J 48 (2016), 808–817.
27. Dara, M, de Colombani, P, Petrova-Benedict, R, et al. Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement. Eur Respir J 40 (2012), 1081–1090.